Astrazeneca (AZN) Prepaid Assets (2016 - 2025)

Astrazeneca has reported Prepaid Assets over the past 11 years, most recently at $2.0 billion for Q4 2025.

For Q4 2025, Prepaid Assets rose 17.1% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, up 17.1%, while the annual FY2025 figure was $2.0 billion, 17.1% up from the prior year.
Prepaid Assets for Q4 2025 was $2.0 billion at Astrazeneca, up from $1.7 billion in the prior quarter.
Over five years, Prepaid Assets peaked at $2.0 billion in Q4 2025 and troughed at $706.0 million in Q1 2021.
A 5-year average of $1.5 billion and a median of $1.6 billion in 2021 define the central range for Prepaid Assets.
Biggest five-year swings in Prepaid Assets: decreased 12.85% in 2021 and later grew 21.67% in 2023.
Year by year, Prepaid Assets stood at $1.5 billion in 2021, then decreased by 12.1% to $1.3 billion in 2022, then increased by 21.67% to $1.6 billion in 2023, then increased by 7.42% to $1.7 billion in 2024, then grew by 17.1% to $2.0 billion in 2025.
Business Quant data shows Prepaid Assets for AZN at $2.0 billion in Q4 2025, $1.7 billion in Q4 2024, and $1.6 billion in Q4 2023.

Peer Comparison